RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kinetigen, Inc., a specialty pharmaceutical consulting firm with global reach, is pleased to announce the addition of Mark Sale, MD to its experienced team of drug development professionals. Dr. Sale strengthens Kinetigen’s core competencies in pharmacokinetics with his extensive background in modeling and simulation. “Dr. Sale is one of the pre-eminent pharmacometricians conducting modeling, simulation, and population PK analyses for pharmaceutical and biotech companies,” said Geoffrey Banks, Ph.D., Kinetigen President and CEO, adding further, “The addition of Dr. Sale as VP of Modeling and Simulation follows our strategic growth initiative to solidify our position as the go-to resource for clinical pharmacology, pharmacokinetics, and model based drug development in the pharmaceutical industry.”
